Tuladhar Sunanda

TL;DR: It is demonstrated that the restoration of the gut microbiome usually improves stroke treatment outcomes by regulating metabolic, immune, and inflammatory responses via the gut–brain axis (GBA).

TL;DR: The etiopathogenic link between gut dysbiosis and depression with preclinical and clinical evidence is summarized and information on the recent therapies and supplements, such as probiotics, prebiotics, short-chain fatty acids, and vitamin B12, omega-3 fatty acid, etc., which target the gut–brain axis (GBA) for the effective management of depressive behavior and anxiety are collated.

TL;DR: In this paper, the authors attempted to update the reports (using various search engines, such as PubMed, SCOPUS, Elsevier, and Springer Nature) demonstrating the pathogenic interactions between the various proteins present in mitochondria, endoplasmic reticulum, and MAM with respect to Parkinson's disease.

TL;DR: This chapter is summarizes the current strategies employed in mitochondrial drug delivery in neurodegenerative diseases addressing the limitations, clinical and regulatory challenges.

TL;DR: A growing body of evidence reveals that alterations in the bacterial composition of the intestinal microbiota (gut dysbiosis) disrupt host immune homeostasis and the intestinal barrier function as discussed by the authors .